Published in Eur Heart J on February 01, 2004
Usefulness of exercise-stress echocardiography for risk stratification of true asymptomatic patients with aortic valve stenosis. Eur Heart J (2010) 1.71
Arterial calcification and bone physiology: role of the bone-vascular axis. Nat Rev Endocrinol (2012) 1.66
Impact of blood pressure on the Doppler echocardiographic assessment of severity of aortic stenosis. Heart (2006) 1.65
The regulation of valvular and vascular sclerosis by osteogenic morphogens. Circ Res (2011) 1.29
Current management of calcific aortic stenosis. Circ Res (2013) 1.18
Molecular and cellular aspects of calcific aortic valve disease. Circ Res (2013) 1.12
Degenerative aortic stenosis. BMJ (2008) 1.07
Aortic valve calcification in mild primary hyperparathyroidism. J Clin Endocrinol Metab (2011) 0.96
Antioxidant enzymes reduce DNA damage and early activation of valvular interstitial cells in aortic valve sclerosis. Arterioscler Thromb Vasc Biol (2012) 0.94
[Aortic stenosis]. Clin Res Cardiol (2006) 0.92
Mitral and aortic valve sclerosis/calcification and carotid atherosclerosis: results from 1065 patients. Heart Vessels (2013) 0.91
Noggin attenuates the osteogenic activation of human valve interstitial cells in aortic valve sclerosis. Cardiovasc Res (2013) 0.91
Aortic sclerosis: not an innocent murmur but a marker of increased cardiovascular risk. Heart (2005) 0.89
Mechanisms of aortic valve calcification: the LDL-density-radius theory: a translation from cell signaling to physiology. Am J Physiol Heart Circ Physiol (2009) 0.85
Strain and strain rate echocardiography findings in children with asymptomatic congenital aortic stenosis. Pediatr Cardiol (2013) 0.84
Prevalence and prognostic impact of comorbidities in patients with severe aortic valve stenosis. Clin Res Cardiol (2006) 0.83
Risk Stratification in Patients With Aortic Stenosis Using Novel Imaging Approaches. Circ Cardiovasc Imaging (2015) 0.82
Impact of chronic kidney disease on the presence and severity of aortic stenosis in patients at high risk for coronary artery disease. Cardiovasc Ultrasound (2011) 0.82
Surgical aspects of congestive heart failure. Heart Fail Rev (2006) 0.80
Risk factors for progression of calcific aortic stenosis and potential therapeutic targets. Int J Angiol (2008) 0.79
Higher ambulatory blood pressure is associated with aortic valve calcification in the elderly: a population-based study. Hypertension (2012) 0.79
Aortic stenosis: even mild disease is significant. Eur Heart J (2004) 0.79
Diagnosis and management of patients with asymptomatic severe aortic stenosis. World J Cardiol (2016) 0.78
Echocardiographic integrated backscatter for detecting progression and regression of aortic valve calcifications in rats. Cardiovasc Ultrasound (2013) 0.77
Progression rate of aortic valve stenosis in korean patients. J Cardiovasc Ultrasound (2010) 0.77
Development of Aortic Valve Disease in Familial Hypercholesterolemic Swine: Implications for Elucidating Disease Etiology. J Am Heart Assoc (2015) 0.77
Real-time imaging required for optimal echocardiographic assessment of aortic valve calcification. Clin Physiol Funct Imaging (2012) 0.76
Medical therapy for rheumatic heart disease: is it time to be proactive rather than reactive? Indian Heart J (2009) 0.76
Exercise stress echocardiography with tissue Doppler imaging in risk stratification of mild to moderate aortic stenosis. Int J Cardiovasc Imaging (2015) 0.76
Sex differences in cardiovascular outcome during progression of aortic valve stenosis. Heart (2014) 0.75
The quest for the unholy grail. Pediatr Cardiol (2008) 0.75
Can severe aortic stenosis be identified by emergency physicians when interpreting a simplified two-view echocardiogram obtained by trained echocardiographers? Crit Ultrasound J (2015) 0.75
Exercise stress echocardiography in patients with aortic stenosis: impact of baseline diastolic dysfunction and functional capacity on mortality and aortic valve replacement. Cardiovasc Diagn Ther (2013) 0.75
Calcific Aortic Valve Disease Is Associated with Layer-Specific Alterations in Collagen Architecture. PLoS One (2016) 0.75
Aortic Valve Replacement for Moderate Aortic Stenosis with Severe Calcification and Left Ventricualr Dysfunction-A Case Report and Review of the Literature. Front Cardiovasc Med (2017) 0.75
Transesophageal echocardiography during cardiac arrest in orthopedic surgery patients: a report of two cases and a review of the literature. HSS J (2013) 0.75
The Role of Imaging in Aortic Valve Disease. Curr Cardiovasc Imaging Rep (2016) 0.75
Predictors of echocardiographic progression in patients with mild aortic stenosis. Korean Circ J (2011) 0.75
Pocket-size imaging device as a screening tool for aortic stenosis. Wien Klin Wochenschr (2015) 0.75
2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J (2013) 12.73
Guidelines on the management of valvular heart disease (version 2012). Eur Heart J (2012) 10.70
2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J (2013) 9.54
Third universal definition of myocardial infarction. J Am Coll Cardiol (2012) 8.59
A solution to the problem of separation in logistic regression. Stat Med (2002) 7.44
Guidelines on the management of valvular heart disease: The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. Eur Heart J (2007) 7.34
Myocardial viability and survival in ischemic left ventricular dysfunction. N Engl J Med (2011) 6.65
Guidelines on the management of valvular heart disease (version 2012): the Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur J Cardiothorac Surg (2012) 5.49
Implementation of guidelines improves the standard of care: the Viennese registry on reperfusion strategies in ST-elevation myocardial infarction (Vienna STEMI registry). Circulation (2006) 3.08
Cardiac magnetic resonance postcontrast T1 time is associated with outcome in patients with heart failure and preserved ejection fraction. Circ Cardiovasc Imaging (2013) 2.47
Outcome of watchful waiting in asymptomatic severe mitral regurgitation. Circulation (2006) 2.46
Projected valve area at normal flow rate improves the assessment of stenosis severity in patients with low-flow, low-gradient aortic stenosis: the multicenter TOPAS (Truly or Pseudo-Severe Aortic Stenosis) study. Circulation (2006) 2.29
Stent thrombosis with ticagrelor versus clopidogrel in patients with acute coronary syndromes: an analysis from the prospective, randomized PLATO trial. Circulation (2013) 2.03
Impact of transcatheter aortic valve implantation or surgical aortic valve replacement on right ventricular function. Heart (2012) 2.03
Statins but not angiotensin-converting enzyme inhibitors delay progression of aortic stenosis. Circulation (2004) 2.03
Impact of transcatheter aortic valve implantation or surgical aortic valve replacement on right ventricular function--the reply. Heart (2012) 1.98
Benefit of atrial septal defect closure in adults: impact of age. Eur Heart J (2010) 1.94
Valve-in-valve transcatheter aortic valve implantation for degenerated bioprosthetic heart valves. JACC Cardiovasc Interv (2011) 1.94
Outcome of pregnancy in patients with structural or ischaemic heart disease: results of a registry of the European Society of Cardiology. Eur Heart J (2012) 1.82
Diastolic pulmonary vascular pressure gradient: a predictor of prognosis in "out-of-proportion" pulmonary hypertension. Chest (2013) 1.72
Gene expression profiling: does it add predictive accuracy to clinical characteristics in cancer prognosis? Eur J Cancer (2007) 1.70
Perioperative beta-blockers for preventing surgery-related mortality and morbidity: a systematic review and meta-analysis. Anesth Analg (2007) 1.65
Reduction in first and recurrent cardiovascular events with ticagrelor compared with clopidogrel in the PLATO Study. Circulation (2012) 1.62
Two dimensional speckle tracking echocardiography: clinical applications. Heart (2010) 1.61
NON-invasive imaging: Two dimensional speckle tracking echocardiography: basic principles. Heart (2010) 1.59
Natriuretic peptides predict symptom-free survival and postoperative outcome in severe aortic stenosis. Circulation (2004) 1.56
Mitral valve repair with the Colvin-Galloway Future Band. Ann Thorac Surg (2004) 1.56
[Guidelines on the management of valvular heart disease (version 2012). The Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)]. G Ital Cardiol (Rome) (2013) 1.53
Vascular dysfunction after coarctation repair is related to the age at surgery. Int J Cardiol (2005) 1.53
Can a commercial diagnostic ultrasound device accelerate thrombolysis? An in vitro skull model. Stroke (2004) 1.51
A multi-biomarker risk score improves prediction of long-term mortality in patients with advanced heart failure. Int J Cardiol (2012) 1.51
Gender differences in clinical presentation and surgical outcome of aortic stenosis. Heart (2010) 1.50
Systemic pressure does not directly affect pressure gradient and valve area estimates in aortic stenosis in vitro. Eur Heart J (2008) 1.49
Outcome of combined stenotic and regurgitant aortic valve disease. J Am Coll Cardiol (2013) 1.47
Long-term outcome of patients with ventricular septal defect considered not to require surgical closure during childhood. J Am Coll Cardiol (2002) 1.46
A modified and simplified radiofrequency ablation in patients with mitral valve disease. J Thorac Cardiovasc Surg (2005) 1.46
Impact of tricuspid regurgitation on survival in patients with chronic heart failure: unexpected findings of a long-term observational study. Eur Heart J (2013) 1.46
The salvage potential of coronary sinus interventions: meta-analysis and pathophysiologic consequences. J Thorac Cardiovasc Surg (2004) 1.45
Congenital heart defects in adulthood. Dtsch Arztebl Int (2011) 1.45
Transcatheter closure of patent foramen ovale with radiofrequency: acute and intermediate term results in 144 patients. Catheter Cardiovasc Interv (2009) 1.40
Meta-Analysis of Cell-based CaRdiac stUdiEs (ACCRUE) in patients with acute myocardial infarction based on individual patient data. Circ Res (2015) 1.39
History of previous bleeding and C-reactive protein improve assessment of bleeding risk in elderly patients (≥ 80 years) with myocardial infarction. Thromb Haemost (2015) 1.38
Inflammation and Carotid Artery--Risk for Atherosclerosis Study (ICARAS). Circulation (2005) 1.32
Natural history of very severe aortic stenosis. Circulation (2009) 1.27
Simvastatin suppresses endotoxin-induced upregulation of toll-like receptors 4 and 2 in vivo. Atherosclerosis (2006) 1.26
Intracoronary thrombectomy with the X-sizer catheter system improves epicardial flow and accelerates ST-segment resolution in patients with acute coronary syndrome: a prospective, randomized, controlled study. Circulation (2002) 1.25
Low number of donor activating killer immunoglobulin-like receptors (KIR) genes but not KIR-ligand mismatch prevents relapse and improves disease-free survival in leukemia patients after in vivo T-cell depleted unrelated stem cell transplantation. Transplantation (2006) 1.24
Exact log-rank tests for unequal follow-up. Biometrics (2003) 1.24
Comparison between antithymocyte globulin and alemtuzumab and the possible impact of KIR-ligand mismatch after dose-reduced conditioning and unrelated stem cell transplantation in patients with multiple myeloma. Br J Haematol (2005) 1.23
B-type natriuretic peptide in low-flow, low-gradient aortic stenosis: relationship to hemodynamics and clinical outcome: results from the Multicenter Truly or Pseudo-Severe Aortic Stenosis (TOPAS) study. Circulation (2007) 1.22
Coronary no-reflow is caused by shedding of active tissue factor from dissected atherosclerotic plaque. Blood (2002) 1.21
Combined delivery approach of bone marrow mononuclear stem cells early and late after myocardial infarction: the MYSTAR prospective, randomized study. Nat Clin Pract Cardiovasc Med (2008) 1.20
Medical conditions increasing the risk of chronic thromboembolic pulmonary hypertension. Thromb Haemost (2005) 1.17
ESC Working Group on Valvular Heart Disease position paper--heart valve clinics: organization, structure, and experiences. Eur Heart J (2013) 1.17
Interleukin-33 induces expression of adhesion molecules and inflammatory activation in human endothelial cells and in human atherosclerotic plaques. Arterioscler Thromb Vasc Biol (2011) 1.16
High-density lipoprotein and the risk of recurrent venous thromboembolism. Circulation (2007) 1.16
Quantification of biventricular myocardial function using cardiac magnetic resonance feature tracking, endocardial border delineation and echocardiographic speckle tracking in patients with repaired tetralogy of Fallot and healthy controls. J Cardiovasc Magn Reson (2012) 1.13
Right ventricular-left ventricular interaction in adults with Tetralogy of Fallot: a combined cardiac magnetic resonance and echocardiographic speckle tracking study. Int J Cardiol (2010) 1.12